Sponsored Links

Cannabis Science Moves Its FDA Clinical Trial Process Forward PDF Print E-mail
Medical News - Alcohol and Addiction
Cannabis Science Inc. (NASD OTCBB: CBIS), a pharmaceutical cannabis company, is pleased to report to their shareholders that the choice of our initial cannabis-based pharmaceutical for FDA clinical trials has been made. The Company has reported several possible drugs for FDA clinical trials...

Read more: Alcohol / Addiction / Illegal Drugs News From Medical News Today